Northwest Biotherapeutics, Inc.

OTC
NWBO
paper.types.company
Rentabilité sur six mois: -3.57%
Rendement en dividendes: 0%
Secteur: Healthcare

0.27 $

+0.0034 $ +1.28%
0.19 $
0.5 $

paper.min_max_per_year

Calendrier des promotions Northwest Biotherapeutics, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors.

plus de détails
The company was founded in 1996 and is headquartered in Bethesda, Maryland.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

ISIN
US66737P6007
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 257.49 1
P/BV -3.77 0
P/E 0 0
Efficacité
Nom Signification Grade
ROA -306.92 0
ROE 104.55 10
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.6428 10
Debt/Ratio 2.34 6
Debt/Equity -1.28 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 6.31 1
Rentabilité Ebitda, % 296.2 10
Rentabilité EPS, % -90.05 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.2666 $ 0 $ 0 $ 1.28 % 0 % 0 %
common.calendar.number_days.7d 0.27 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 0.28 $ 0.2666 $ 0.29 $ -3.57 % 0 % 0 %
common.calendar.number_days.90d 0.26 $ 0.19 $ 0.44 $ 3.85 % 0 % 0 %
common.calendar.number_days.180d 0.28 $ 0.19 $ 0.44 $ -3.57 % 0 % 0 %
common.calendar.number_days.1y 0.45 $ 0.19 $ 0.5 $ -40 % 0 % 0 %
common.calendar.number_days.3y 0.68 $ 0.19 $ 1.15 $ -60.29 % 0 % 0 %
common.calendar.number_days.5y 0.17 $ 0.19 $ 2.3 $ 58.82 % 0 % 0 %
common.calendar.number_days.10y 0 $ 0.1411 $ 12.24 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 0.28 $ 0.19 $ 0.44 $ -3.57 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Ms. Linda F. Powers J.D. Chairperson, CEO, President, CFO & Chief Accounting Officer 925k 1956 (69 années)
Dr. Alton L. Boynton Ph.D. Founder, Chief Scientific Officer, Secretary & Director 375k 1945 (80 années)
Dr. Marnix L. Bosch M.B.A., Ph.D. Chief Technical Officer 453.6k 1959 (66 années)
Mr. Leslie J. Goldman Senior VP & General Counsel 725k 1945 (80 années)
Mr. David Innes Vice President of Investor Relations N/A

Informations sur l'entreprise

Adresse: United States, Bethesda. MD, 4800 Montgomery Lane - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.nwbio.com